[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344810-105":59,"doc-detail-344810-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mir-596-as-a-novel-prognostic-biomarker-and-tumor-suppressor-in-breast-cancer-through-targeting-eif5al1","miR-596 as a novel prognostic biomarker and tumor suppressor in breast cancer through targeting EIF5AL1","","Breast cancer remains the leading cause of cancer-related mortality among women worldwide. This study investigates miR-596 in 137 enrolled subjects using qRT-PCR, confirming the regulatory interaction between miR-596 and EIF5AL1 with dual-luciferase reporter assays. Functional effects on MCF-7 and MDA-MB-231 cells are assessed by CCK-8 and Transwell assays for proliferation, migration, and invasion.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mir-596-as-a-novel-prognostic-biomarker-and-tumor-suppressor-in-breast-cancer-through-targeting-eif5al1/344810/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mir-596-as-a-novel-prognostic-biomarker-and-tumor-suppressor-in-breast-cancer-through-targeting-eif5al1/344810.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was miR-596 expression measured in this study?","Question",{"text":112,"@type":113},"qRT-PCR was used to measure miR-596 expression in tissue and cell samples from 137 enrolled subjects.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What method verified the interaction between miR-596 and EIF5AL1?",{"text":117,"@type":113},"Dual-luciferase reporter assays were used to verify the regulatory interaction between miR-596 and EIF5AL1.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects did miR-596 reintroduction have on breast cancer cells?",{"text":121,"@type":113},"Reintroduction of miR-596 markedly suppressed proliferation, migration, and invasion in MCF-7 and MDA-MB-231 cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344810,1790456207,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Huang et al. Hereditas (2026) 163:28 [https://doi.org/10.1186/s41065-026-00641-6](https://doi.org/10.1186/s41065-026-00641-6)  \nHereditas  \nRESEARCH Open Access  \nmiR-596 as a novel prognostic biomarker and tumor suppressor in breast cancer through targeting EIF5AL1  \nRui Huang1†, Yan Jiang2†, Yan Bian3, Dengyuan Zhong4* and Baoyong Lv5*  \nAbstract  \nBackground In terms of global incidence and mortality, breast cancer continues to surpass all other cancers affecting women.  \nMethods To explore the role of miR-596, qRT-PCR was applied to measure its expression in tissue and cell samples from 137 enrolled subjects. The regulatory interaction between miR-596 and EIF5AL1 was verified by dual-luciferase reporter assays. CCK-8 and Transwell assays were utilized to respectively measure the proliferation, migration, and invasion capabilities of the two breast cancer cell lines, MCF-7 and MDA-MB-231 .  \nResults A significant downregulation of miR-596 was observed in breast cancer tissues and cell lines (all P \u003C 0. 001) . Clinically, reduced miR-596 expression was associated with advanced TNM stage, lymph node metastasis, and inferior overall survival (P \u003C 0. 05) . EIF5AL1 was validated as a direct target gene of miR-596, and their expression levels were inversely correlated in clinical samples (r = -0 . 801, P \u003C 0. 001) . Reintroduction of miR-596 markedly suppressed the proliferation, migration, and invasion of cancer cells, effects that were largely reversed by overexpressing EIF5AL1 (all P \u003C 0. 001) .  \nConclusion In breast cancer, miR-596 suppresses malignancy and predicts prognosis by targeting EIF5AL1 . Thus, therapeutic modulation of this axis offers novel avenues for treatment and risk assessment.  \nKeywords Breast cancer, MiR-596, EIF5AL1, Proliferation, Migration, Prognosis  \n†Rui Huang andYan Jiang contributed equally to this work.  \n*Correspondence:  \nDengyuan Zhong  \n[zhongdengyuan02@163.com](zhongdengyuan02@163.com)  \nBaoyong Lv  \n[lvbaoyong339@163.com](lvbaoyong339@163.com)  \n1Academic Theory Research Department, Mudanjiang Medical University, Mudanjiang 157011, China  \n2One Departments of Cadre Ward, General Hospital of Southern Theater Command of Chinese PLA, Guangzhou 510010, China  \n3Xi’an International University, Xi’an 710077, China  \n4Department of Surgery II, The People’s Hospital of Shuangqiao Economic-Technological Development Zone, No. 6, Checheng Avenue, Chongqing, China400900  \n5General Surgery, SHOUGUANG HOSPITAL OFT. C. M, No. 3353, Shengcheng Street, Shouguang 262700, China  \nIntroduction  \nBreast cancer continues to be the most frequently diagnosed cancer and represents the leading cause of cancerrelated deaths in women worldwide, posing a substantial challenge to public health [1]. According to the International Agency for Research on Cancer, in 2022, this disease accounted for 23.8% of all incident cancers and 15.4% of female cancer fatalities, globally ranking fourth among all cancers in terms of mortality [2]. Although treatment strategies have improved considerably, the persistently high incidence and fatality rates of breast cancer continue to present considerable challenges to women’s health [3]. The frequent absence of obvious symptoms  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the c","cbCaiu5zZRMVhO7S","https://ap.wps.com/l/cbCaiu5zZRMVhO7S","pdf",4450245,"English","# Abstract\n# Introduction","[{\"question\":\"How was miR-596 expression measured in this study?\",\"answer\":\"qRT-PCR was used to measure miR-596 expression in tissue and cell samples from 137 enrolled subjects.\"},{\"question\":\"What method verified the interaction between miR-596 and EIF5AL1?\",\"answer\":\"Dual-luciferase reporter assays were used to verify the regulatory interaction between miR-596 and EIF5AL1.\"},{\"question\":\"What functional effects did miR-596 reintroduction have on breast cancer cells?\",\"answer\":\"Reintroduction of miR-596 markedly suppressed proliferation, migration, and invasion in MCF-7 and MDA-MB-231 cells.\"}]","miR-596 as a novel prognostic biomarker and tumor suppressor in breast cancer through targeting EIF5AL1 | PDF",1790055341,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d661adca8fd27341a4fd3c0ded4d5ca.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21cf0442b5c34fb72cd97b853e626878.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c7b82af6aae68e534018b6f7e2a58b2.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e58f90bd4c53ea871ce8894f6232624e.webp",980,1306]